Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 15816271Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2024
Linked Award Amount
$2.6M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#3,450
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Matthew Golden as a PI. Multi-PI records show the full award amount for context.
- 1SB1AG087924-01SB1Adding technology that will enhance commercialization of our neuroscience-based innovative assistive technology platform for living with Alzheimer's disease and Alzheimer's disease related dementia$1.2Maward amount
- 5R44AG076256-03R44An assistive-technology based Caregiver Training Program (CTP) to enhance caregiver effectiveness, well-being, and quality of life, which will improve overall care for individuals living with AD/ADRD.$1.2Maward amount
- 3R44AG076256-03S1R44An assistive-technology based Caregiver Training Program (CTP) to enhance caregiver effectiveness, well-being, and quality of life, which will improve overall care for individuals living with AD/ADRD.$88.1Kaward amount
- 3R44AG076256-02S1R44An assistive-technology based Caregiver Training Program (CTP) to enhance caregiver effectiveness, well-being, and quality of life, which will improve overall care for individuals living with AD/ADRD.$45.4Kaward amount
Award organization
Organizations that administered FY2024 awards listing Matthew Golden as a PI.
FY2024 award administered by Maphabit, Inc. (GA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMaphabit, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #3450
- 2024Entered Top 25% NationallyRanked #3450
- 2026$5M Cumulative Funding